Company · CIK 0001984086 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Septerna, Inc. · SEPN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 SForm 4 → | Sep 3, 7:01 pm EDT | Daniel D. LongSVP, Drug Discovery | 3,333 | $37.83 | $126,078 | 96,412 | −3.34% | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 7:01 pm EDT | Daniel D. LongSVP, Drug Discovery | 3,333 | $2.76 | $9,199 | 99,745 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 AForm 4 → | Sep 10, 5:08 pm EDT | Rajiv PatniChief Medical Officer | 275,000 | — | — | 275,000 | — | |
| Sep 1, 2026 MForm 4 → | Sep 3, 7:01 pm EDT | Daniel D. LongSVP, Drug Discovery | 3,333 | — | — | 9,085 | — | 10b5-1 |